Recently Viewed
Clear All$11.04
$0.00 (0.00%)As on 10-May-2023 09:30EDT
Today’s Range
52 Week Range
Liquidity
Market cap
$65 Mln
Revenue (TTM)
$0 Mln
Net Profit (TTM)
$7 Mln
ROE
0 %
ROCE
-- %
P/E Ratio
23
P/B Ratio
0
Industry P/E
--
EV/EBITDA
0
Div. Yield
0 %
Debt to Equity
0
Book Value
$--
EPS
$--
Face value
--
Shares outstanding
690,139
CFO
$--
EBITDA
$--
Net Profit
$--
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Intelligent Medicine Acquisition Corp (IQMD)
| 7.4 | 7.2 | 7.7 | 10.4 | -- | -- | -- |
|
BSE Sensex*
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Intelligent Medicine Acquisition Corp (IQMD)
|
11.0 | 64.8 | 0.0 | 9.9 | -- | 4.9 | 23 | 0.0 |
| 10.2 | 225.7 | 0.0 | 5.6 | -- | 3.2 | 40.7 | 1.3 | |
| 10.6 | 303.3 | 0.0 | 3.9 | -- | 1.7 | 263.8 | 0.0 | |
| 10.6 | -- | 0.0 | 5.2 | -- | 2.2 | -- | 0.0 |
Intelligent Medicine Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more... businesses. It intends to identify business opportunities in the field of life science. The company was incorporated in 2021 and is based in Bethesda, Maryland. Read more
CEO, CFO & Director
Mr. Gregory C. Simon
CEO, CFO & Director
Mr. Gregory C. Simon
Headquarters
Bethesda, MD
Website
--
Our rating system has guided millions of investors in the past 20 years.
The share price of Intelligent Medicine Acquisition Corp (IQMD) is $11.04 (NASDAQ) as of 10-May-2023 09:30 EDT. Intelligent Medicine Acquisition Corp (IQMD) has given a return of 10.4% in the last 1 years.
The P/E ratio of Intelligent Medicine Acquisition Corp (IQMD) is 23.00 times as on 10-May-2023.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2022
|
--
|
--
|
|
2021
|
--
|
--
|
|
2022
|
--
|
--
|
|
2021
|
--
|
--
|
The 52-week high and low of Intelligent Medicine Acquisition Corp (IQMD) are Rs -- and Rs -- as of 02-Apr-2026.
Intelligent Medicine Acquisition Corp (IQMD) has a market capitalisation of $ 65 Mln as on 10-May-2023. As per SEBI classification, it is a Small Cap company.
Before investing in Intelligent Medicine Acquisition Corp (IQMD), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.